Biolyte

Quick links to important sections

Biolyte

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Biolyte

This section provides a factual overview of the sterile intravenous solution known as Biolyte, adhering strictly to its identity, composition, and high-level classification.


Quick Facts: Biolyte (Compound Sodium Lactate)

Property Description
Active Ingredients Sodium Lactate, Sodium Chloride, Potassium Chloride, Calcium Chloride Dihydrate
Form Sterile solution for intravenous use
Pharmacological Class Systemic Alkalinizer and Electrolyte Replenisher
General Purpose Fluid restoration and acid-base balance correction
Origin Synthetic combination product

Biolyte: Identity and Pharmaceutical Classification

Biolyte is the trade name for Compound Sodium Lactate Solution, a widely used, sterile combination product administered as an intravenous fluid. It is classified simultaneously as an Electrolyte Replenisher and a Systemic Alkalinizer, indicating its dual role in balancing the body's fluid volume and its pH level. This specific combination formulation, which is clinically recognized for its balanced electrolyte profile, is commonly and interchangeably known globally as Hartmann's Solution or Lactated Ringer's Solution across clinical settings.

What is Biolyte Composed of, and How Does it Work Generally?

The solution's high-level composition includes four key active ingredients: Sodium Lactate (NaC3H5O3), Sodium Chloride (NaCl), Potassium Chloride (KCl), and Calcium Chloride Dihydrate (CaCl2 cdot 2H2O), all dissolved in an aqueous vehicle (Water for Injection). This specific inclusion of Calcium Chloride differentiates the compound solution from simpler electrolyte solutions.

When administered, the salts replenish depleted electrolytes that are necessary for normal cell function. Crucially, the Sodium Lactate component acts as a bicarbonate precursor; it is metabolized by the liver into the acid-neutralizing agent, bicarbonate (HCO3^-). This conversion helps correct plasma pH when a bicarbonate deficiency exists in the body. This process provides a stable and gradual means of helping the body regain its crucial acid-base balance.

General Purpose of this Intravenous Fluid

The general purpose of this specific sterile solution is the rapid restoration of physiological stability during acute stress, such as when a patient experiences significant fluid or blood volume loss. It is administered to quickly replace necessary fluids and electrolyte salts and to help reverse an overly acidic state in the blood, known as metabolic acidosis. This quick and balanced replenishment aids in maintaining the internal fluid environment when the patient cannot sustain fluid intake orally.

Regulatory References

  1. U.S. National Institutes of Health (NIH)
  2. NIH DailyMed

What side effects are possible with Biolyte?

Possible side effects and safety information

Official Regulatory Safety Profile

The official safety information for Biolyte (Compound Sodium Lactate Solution) is primarily defined by its effects on Metabolism and Nutrition Disorders and conditions related to its Administration Site. Adverse reactions are often classified with a Frequency Not Known designation, based on post-marketing reports rather than controlled trial data.

Key risks documented in regulatory labels relate to the solution's volume and electrolyte content, leading to possible fluid overload (hypervolemia) and severe electrolyte imbalances such as hyperkalemia, hypernatraemia, hyponatremia, and metabolic alkalosis. Administration-related events may include febrile response, phlebitis, or infection at the site of infusion.


Clinically Significant Adverse Reactions and Restrictions

Specific serious adverse events are highlighted in official documents:

  • Acute Hyponatraemic Encephalopathy: A severe, potentially life-threatening brain complication associated with severe hyponatremia.
  • Fatal Precipitation Risk: The product is contraindicated in neonates (leq 28 days) receiving the antibiotic ceftriaxone due to the risk of fatal precipitation of calcium salts in the body.
  • Coagulation Risk: The solution's calcium content poses a risk of coagulation if administered through the same line as blood products.

Population and Organ Function Safety Constraints

Safety constraints require particular caution or restriction in specific patient groups. Patients with severe renal impairment face an increased risk of hyperkalaemia and fluid retention. Those with severe hepatic insufficiency are contra-indicated due to impaired metabolism of the lactate component, which increases the risk of metabolic acidosis. The labels specify an increased risk of hyponatremia and related complications in pediatric patients and older adults.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Biolyte (Compound Sodium Lactate) is officially documented to result from the administration of excessive volumes or an excessively rapid infusion rate. The documented manifestations center on fluid and solute overload, which may lead to clinical signs such as generalized oedema (swelling) and pulmonary oedema (fluid on the lungs). The physiological systems most affected are Fluid and Electrolyte Balance, the Central Nervous System (CNS), and the Cardiovascular System.

Overdose may cause severe disturbances in the body's chemistry, including Hypernatraemia, Hyperkalaemia, and Metabolic Alkalosis. The most serious documented outcomes involve the CNS, such as acute hyponatraemic encephalopathy (brain swelling) which can be life-threatening and may present with confusion and seizures. Pediatric patients are noted to be at an increased risk for this severe complication.

The effects of overdose require immediate medical attention and treatment. Regulatory instructions mandate that the infusion must be stopped immediately upon detection of overdose signs. Management involves directing symptomatic and supportive treatment, with potential requirements for Extra Renal Dialysis in severe cases of water and sodium overload. Close and continuous monitoring of serum electrolytes and fluid balance is required during overdose management.

Therapeutic Uses of Biolyte

What Biolyte Treats: Main Uses and Benefits

Biolyte is generally applied in clinical settings that involve acute or unstable symptom patterns related to fluid balance. It is commonly used when short-term symptomatic assistance is needed to address critical physiological deficits. The solution is recognized for its relevance across several domains where fluid replacement and electrolyte support are vital.

Clinical Support and Benefits

Biolyte is used in managing symptoms that create noticeable physiological strain from conditions like hypovolemia, severe dehydration, and systemic metabolic acidosis. It is used to support patients during episodes of acute hemorrhage, extensive burns, and significant fluid loss associated with surgical procedures.

The primary benefit is hemodynamic stabilization, which may assist with maintaining blood pressure and supports the management of rapid heart rate that accompany circulatory instability. The solution contributes to easing the overall symptom load by addressing deficits in essential minerals and assists with maintaining functional stability by correcting the systemic acid-base imbalance.

“This therapy is commonly used in acute care to provide supportive fluid and electrolyte support in situations where a patient's internal balance may be significantly affected.”

Quick Fact: Relief for Acute Distress
Symptom Category: Circulatory Instability
Primary Benefit: Supports stabilization of blood volume and pressure
Typical Context: Emergency or post-trauma resuscitation

Regulatory References

  1. DailyMed listing for Compound Sodium Lactate Solution

Eligibility and Restrictions for Use

Official Eligibility Rules for Biolyte (Compound Sodium Lactate)

Biolyte is officially allowed for use in Adults and Pediatric patients as a source of water and electrolytes, based on its regulatory approval.

Contraindicated Populations (Must Not Use) Age-Related Restrictions
Neonates (leq 28 days) receiving the antibiotic Ceftriaxone Infants lt 6 months require particular caution due to lactate metabolism concerns
Patients with known Hypersensitivity to any component Older Adults (Geriatric) require cautious dose selection due to likely reduced organ function
Patients with Severe Renal Insufficiency (with oliguria/anuria)
Patients with Uncompensated Cardiac Failure or Extracellular Hyperhydration
Patients with Severe Metabolic Alkalosis or Severe Hepatocellular Insufficiency
Patients with pre-existing Hyperkalemia, Hypernatremia, or Hypercalcaemia

Use is restricted, requiring special caution, in patients with Congestive Heart Failure and those with Mild to Moderate Renal Impairment. Regarding Pregnancy and Lactation, the solution can generally be used with care when clinically needed and is often considered acceptable.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Biolyte (Compound Sodium Lactate Solution) is structured around its electrolyte composition and its regulatory-documented systemic alkalinizing effect.

Pharmacodynamic Interactions and Constraints

Co-administration with agents that affect potassium balance, such as ACE inhibitors, ARBs, Potassium-sparing diuretics, or certain Immunosuppressants, increases the risk of hyperkalemia. Due to the calcium component, combining the solution with Digitalis Glycosides (Digoxin) is associated with an increased risk of serious cardiac arrhythmia. Additive effects with Corticosteroids may enhance the risk of sodium and fluid retention.

  • Contraindicated Combination: An absolute prohibition exists for co-administration with Ceftriaxone in neonates (le 28 days of age) due to the risk of fatal precipitation.
  • Timing Rule: The solution must not be administered simultaneously with citrate anticoagulated blood or through the same line as Ceftriaxone; thorough line flushing is mandatory between sequential infusions.

Pharmacokinetic Exposure Modification

The metabolism of the lactate component results in urine pH alteration, which is documented to modify the renal clearance of other drugs. This mechanism can increase the excretion of acidic drugs like Salicylates and Barbiturates, potentially reducing their systemic exposure. Conversely, the clearance of alkaline drugs like Sympathomimetics may be decreased, potentially increasing their exposure.

Population-Specific Interaction Notes

The risk of hyperkalemia-related interactions with Biolyte is noted to be heightened in patients with Severe Renal Impairment.

Mechanism of Action

How Biolyte Works: Mechanism of Action

Fluid and Electrolyte Transport via SGLT1 Activation

This domain describes the primary action on the small intestine, where the specific molar ratio of sodium and glucose activates the Sodium-Glucose Co-transporter 1 ( SGLT1). This molecular mechanism initiates a rapid osmotic cascade, leading to a net movement of water and essential mineral ions into the plasma volume. This action influences the osmotic gradient, resulting in a modulation of systemic fluid balance and transmembrane ionic concentrations.


Support for Cellular Energy and Metabolic Pathways

This mechanism involves providing key substrates and co-factors like L-Carnitine and B-vitamins, which interact with intrinsic metabolic cycles such as the Krebs cycle and beta-oxidation. This action influences the cell’s capacity to generate ATP (cellular energy) and modulates the efficiency of metabolic processing in active cells. The involvement of these components influences the efficiency of ATP generation in cellular energy pathways.


Homeostatic Modulation of Electrical and Ionic Balance

This component involves the reintroduction of balanced electrolytes at concentrations required for maintaining the electrical potential across cell membranes. By supplying these ions, the mechanism supports the functional parameters of active transport systems like the Na^+/ K^+- ATPase pump. The presence of these ions modulates the resting membrane potential, influencing nerve impulse transmission and muscle cell excitability.

Dosage and Administration Information

How Biolyte is Used

Biolyte (Compound Sodium Lactate Solution) administration is a precise procedure and must be performed by a healthcare professional. This section outlines the instructions for its proper use.


Official Administration Guidelines

Guideline Area Official Instruction
Route of Administration Strictly via intravenous (IV) infusion only.
Standard Adult Dosing Daily volume typically ranges from 500 mL to 3 Liters over 24 hours, controlled by a prescribed infusion rate (e.g., approximately 40 mL/kg/24 hours).
Use Pattern Continuous or repeated administration as required for acute fluid and volume management.

Procedural and Population-Specific Rules

Proper administration requires specific procedural steps:

  • Preparation Check: The solution must be clear and particle-free prior to use, and the container must be visually inspected for integrity.
  • Technique: A sterile and non-pyrogenic IV administration set must be used, and the infusion should be started immediately after preparation.
  • Handling Restriction: It is warned not to connect flexible plastic containers in series due to the risk of air embolism.

Dosage Adjustments for Specific Groups:

  • Pediatric Use: The recommended dosage for infants and children is typically in the range of 20 mL to 100 mL/kg per 24 hours.
  • Organ Impairment: Lower volumes and slower infusion rates are advised for patients with cardiac failure, renal impairment, or severe hepatic insufficiency.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Biolyte (Compound Sodium Lactate)


Evidence for Fluid Resuscitation in Critical Care

The solution, known in clinical settings as a balanced crystalloid, was studied in research exploring its role in fluid resuscitation for patients experiencing critical conditions like severe sepsis or shock. The main research foundation includes large, pragmatic Randomized Controlled Trials (RCTs) and Systematic Reviews primarily involving critically ill adult patients. Research explored several major patient outcomes, including all-cause mortality at 28 and 90 days, incidence of Acute Kidney Injury (AKI), and the need for renal replacement therapy. Findings describe patterns observed in the studies, often involving the study of multiple crystalloid solutions, such as normal saline.

Studies on Metabolic Acidosis Correction

Biolyte was evaluated in studies for its properties as a Systemic Alkalinizer. These studies, typically short-term RCTs, explored the association between the solution's administration and changes in specific biochemical markers, focusing on shifts in blood pH and serum bicarbonate levels. Follow-up durations were limited in most of this research, as the focus was on immediate chemical stability. Evidence is limited regarding how these immediate chemical changes correlate with, or impact, patient survival or other long-term outcomes.

Research Gaps and Remaining Uncertainties

The research landscape has limitations. The consistency of findings across large-scale trials, particularly regarding 90-day mortality, shows variability. Subgroup findings are uncertain, especially for patients with specific conditions like severe traumatic brain injury. Furthermore, the correlation between observed short-term biochemical shifts and eventual patient-centered outcomes like quality of life or long-term functional status is not fully established.

Key Studies & References

  1. Lactated Ringer's Injection (Compound Sodium Lactate) - NIH DailyMed Monograph
  2. Intravenous fluids in adults in hospital: Clinical guideline [NICE Guideline NG46] (Evidence summary for General Fluid Use)

Frequently Asked Questions (FAQ)

Common questions about Biolyte (FAQ)


Q: Is Biolyte the same as the popular electrolyte drink of a similar name?

According to official regulatory documents, Biolyte is a sterile solution intended strictly for administration by intravenous (IV) infusion. It is used in clinical settings to replenish fluids and electrolytes. The product is not intended for oral consumption, unlike commercial electrolyte drinks.


Q: How quickly should I expect Biolyte to start working?

Due to its intravenous route of administration, the effect on fluid volume restoration is considered rapid. The lactate component in the solution, which acts to correct acidity, is metabolized by the body over a short period. Effectiveness is monitored by the treating healthcare professional through clinical and laboratory assessments.


Q: What happens if I stop taking Biolyte suddenly?

Biolyte is administered by a healthcare professional in a clinical setting and is not a drug that a patient would take on their own schedule or discontinue suddenly. Its use is determined by the healthcare team based on the patient's acute fluid and volume needs.


Q: Is Biolyte addictive or habit-forming?

The official prescribing information for Biolyte does not contain any warnings regarding abuse potential or the risk of dependency. This solution is generally administered on an acute or short-term basis in a hospital setting.


Q: What is the difference between Biolyte and a generic version?

Biolyte is the trade name for Compound Sodium Lactate Solution. Generic versions are typically marketed under the chemical name. Both the branded and generic versions contain the same active ingredients and are approved for the same specific uses.


Q: Can Biolyte affect my ability to drive or operate machinery?

Regulatory documents state that the effects of Biolyte on a patient's ability to drive or use machinery have not been specifically investigated. Patients receiving this solution are generally in a clinical setting.


Q: Does Biolyte have a warning about interaction with alcohol?

Regulatory documents do not include specific warnings or contraindications regarding the concurrent use of Biolyte and alcohol. Patients should discuss all concurrent substance use, including alcohol, with their healthcare team.


Q: How long after starting Biolyte do I need to see if it’s working?

Biolyte is administered for the rapid replacement of fluid and electrolytes during acute conditions. The determination of effectiveness is based on clinical and laboratory assessments performed by healthcare providers, not a patient’s self-assessment over a prolonged period.


Q: What should I do if I experience a serious side effect with Biolyte?

Patients who experience an unexpected or serious adverse reaction are advised to inform the healthcare professionals supervising the infusion and administering their care. Promptly informing the medical team allows for proper assessment and management.


Q: Are there any dietary restrictions I need to follow while taking Biolyte?

Regulatory documents do not list any specific food or dietary restrictions required while a patient is receiving Biolyte. The focus is on drug-drug and blood product interactions.


Q: Is the active ingredient in Biolyte found in other medicines?

Official product information notes that Biolyte contains common electrolyte salts like Sodium Chloride and Potassium Chloride. These active components are widely found in many different types of medical products and other electrolyte replacement solutions.


Q: Why does the packaging for Biolyte have a warning about sun exposure?

Official regulatory documents for Biolyte do not contain warnings regarding sun exposure or photosensitivity. If a specific warning is seen, it may relate to product storage or handling requirements, not the drug itself.


Q: How can I tell if my Biolyte is expired?

The product's shelf life and expiration date are marked on the container by the manufacturer. The solution must not be used after the printed date to ensure its stability and sterility.


Q: Is Biolyte often prescribed in combination with other drugs?

The official label describes several specific drugs that Biolyte can interact with, and it outlines rules for co-administration. This indicates that it is intended for use as part of a patient's overall medical treatment plan which may involve other medications.


Q: Is it possible to develop a tolerance to Biolyte?

Tolerance is not listed in the pharmacological properties of Biolyte. Since the solution is generally administered on an acute or short-term basis for fluid and electrolyte balance, the development of tolerance is not a reported concern.


Q: What is the non-medical term for the main component of Biolyte?

Biolyte is the trade name for Compound Sodium Lactate Solution. This specific formulation is commonly and interchangeably known across clinical settings by the names Hartmann's Solution or Lactated Ringer's Solution.


Q: Are there different strengths or formulations of Biolyte available?

Official regulatory documents typically specify that Biolyte is available in one standard strength of the Compound Sodium Lactate Solution formulation. All components must be present in the approved concentration ratio.


Q: What evidence exists about Biolyte's use in people with diabetes?

Official warnings and precautions indicate that Biolyte requires special caution when used in patients with diabetes mellitus. This is because the lactate component can be converted into glucose, carrying the potential for hyperglycemia (high blood sugar).


Q: Is Biolyte considered a first-line treatment option?

Official documents describe Biolyte's use in fluid resuscitation for critical care and the correction of metabolic acidosis as one of the options examined in clinical research. The documents do not use the specific phrase 'first-line' to rank its use against other treatments.


Q: Can Biolyte cause weight gain or weight loss?

Regulatory labels identify a key risk as fluid overload ( hypervolemia) and peripheral edema (swelling). Volume overload is a potential risk listed in the product information, which can involve temporary weight gain due to water retention.


Q: What are the most common side effects people report when starting Biolyte?

The frequency of many adverse reactions is classified as 'not known' in regulatory documents. This means there is no official, definitive listing of the most common side effects for the general public. The known risks are primarily related to fluid volume and electrolyte balance.


Q: Can I take Biolyte with my vitamins and supplements?

The label focuses on interactions with prescription drugs. However, the solution's alkalinizing effect may modify the excretion of other substances, including those found in some supplements.


Q: Are there any long-term effects of taking Biolyte?

Clinical research is described as mainly focusing on short-term biochemical effects and acute outcomes. Evidence concerning long-term functional status or effects is not fully established in the primary research foundation.


Q: Does taking Biolyte mean I can't take certain herbal supplements?

The official interaction profile focuses on prescription drugs. The solution's alkalinizing effect may modify the excretion of other substances, which includes those found in some herbal supplements. The potential for these interactions should be discussed with a healthcare professional.


Q: Does Biolyte interact with common pain relievers like ibuprofen?

The solution is documented to increase the excretion of certain acidic drugs, such as Salicylates. While ibuprofen is not specifically named, changes in urine pH caused by Biolyte may potentially affect the way some pain relievers are processed by the body.


Q: Can I use Biolyte if I am currently trying to become pregnant?

The official documentation states that Biolyte can generally be used with care when clinically needed during pregnancy and lactation. Its use when trying to conceive is determined by a healthcare provider.


Q: What is the key takeaway about Biolyte from major research papers?

Major research findings describe Biolyte as a balanced crystalloid studied for its role in fluid resuscitation for critical care patients. Its key action is its ability to act as a Systemic Alkalinizer to quickly help correct blood acidity.

How should Biolyte be stored and disposed of?

The official labeling for Biolyte (Compound Sodium Lactate Solution) mandates specific storage and handling requirements to maintain its sterility and stability.

Official Storage Conditions

  • Temperature: Store at controlled room temperature, typically 20^circC to 25^circC. Excursions between 15^circC and 30^circC are permitted.
  • Prohibited: The product must not be frozen.
  • Container Integrity: Store in the original container until immediate use. Do not use if the seal is compromised or the solution is not clear.
  • Child Safety: Keep out of the sight and reach of children.

Disposal Requirements

All unused product, waste materials, and containers must be disposed of in accordance with local regulations and institutional pharmaceutical waste policies. It should not be placed in household trash or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Biolyte found in:

A-Z Index: